These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 30420350

  • 1. Is there a correlation between an eGFR slope measured over a 5-year period and incident cardiovascular events in the following 5 years among a Flemish general practice population: a retrospective cohort study.
    Van Pottelbergh G, Mamouris P, Opdeweegh N, Vaes B, Goderis G, Van Den Akker M.
    BMJ Open; 2018 Nov 12; 8(11):e023594. PubMed ID: 30420350
    [Abstract] [Full Text] [Related]

  • 2. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Chen Y, Zelnick LR, Huber MP, Wang K, Bansal N, Hoofnagle AN, Paranji RK, Heckbert SR, Weiss NS, Go AS, Hsu CY, Feldman HI, Waikar SS, Mehta RC, Srivastava A, Seliger SL, Lash JP, Porter AC, Raj DS, Kestenbaum BR, CRIC Study Investigators.
    Am J Kidney Dis; 2021 Aug 12; 78(2):226-235.e1. PubMed ID: 33421453
    [Abstract] [Full Text] [Related]

  • 3. Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes.
    Bello AK, Hemmelgarn B, Lloyd A, James MT, Manns BJ, Klarenbach S, Tonelli M, Alberta Kidney Disease Network.
    Clin J Am Soc Nephrol; 2011 Jun 12; 6(6):1418-26. PubMed ID: 21527648
    [Abstract] [Full Text] [Related]

  • 4. Magnitude of rate of change in kidney function and future risk of cardiovascular events.
    Turin TC, Jun M, James MT, Tonelli M, Coresh J, Manns BJ, Hemmelgarn BR.
    Int J Cardiol; 2016 Jan 01; 202():657-65. PubMed ID: 26453813
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular risk in mild to moderately decreased glomerular filtration rate, diabetes and coronary heart disease in a southern European region.
    Gil-Terrón N, Cerain-Herrero MJ, Subirana I, Rodríguez-Latre LM, Cunillera-Puértolas O, Mestre-Ferrer J, Grau M, Dégano IR, Elosua R, Marrugat J, Ramos R, Baena-Díez JM, Salvador-González B.
    Rev Esp Cardiol (Engl Ed); 2020 Mar 01; 73(3):212-218. PubMed ID: 30709697
    [Abstract] [Full Text] [Related]

  • 6. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL, Knoll GA, Petrcich W, Hiremath S, Ruzicka M, Burns KD, Edwards C, Bugeja A, Rhodes E, Sood MM.
    Am J Kidney Dis; 2021 Feb 01; 77(2):178-189.e1. PubMed ID: 32920153
    [Abstract] [Full Text] [Related]

  • 7. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ, Evans M, Szummer K, Spaak J, Lindhagen L, Edfors R, Stenvinkel P, Jacobson SH, Jernberg T.
    JAMA; 2014 Mar 05; 311(9):919-28. PubMed ID: 24595776
    [Abstract] [Full Text] [Related]

  • 8. Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial.
    Oulhaj A, Aziz F, Suliman A, Eller K, Bentoumi R, Buse JB, Al Mahmeed W, von Lewinski D, Coleman RL, Holman RR, Sourij H.
    Diabetes Obes Metab; 2024 Oct 05; 26(10):4602-4612. PubMed ID: 39086032
    [Abstract] [Full Text] [Related]

  • 9. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
    Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, Pérez de Jose A, Cedeño S, Linares T, Luño J.
    Am J Kidney Dis; 2015 Apr 05; 65(4):543-9. PubMed ID: 25595565
    [Abstract] [Full Text] [Related]

  • 10. Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study.
    Zhang L, Hauske S, Ono Y, Kyaw MH, Steubl D, Naito Y, Kanasaki K.
    BMJ Open; 2022 Feb 23; 12(2):e052246. PubMed ID: 35197338
    [Abstract] [Full Text] [Related]

  • 11. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR.
    Nephrol Dial Transplant; 2012 Oct 23; 27(10):3835-43. PubMed ID: 22764191
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors.
    Cea Soriano L, Johansson S, Stefansson B, Rodríguez LA.
    Cardiovasc Diabetol; 2015 Apr 18; 14():38. PubMed ID: 25909295
    [Abstract] [Full Text] [Related]

  • 13. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.
    Rahman M, Xie D, Feldman HI, Go AS, He J, Kusek JW, Lash J, Miller ER, Ojo A, Pan Q, Seliger SL, Steigerwalt S, Townsend RR, CRIC Study Investigators.
    Am J Nephrol; 2014 Apr 18; 40(5):399-407. PubMed ID: 25401485
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B, Hasvold P, Kragsterman B, Falkenberg M, Johansson S, Thuresson M, Nordanstig J.
    J Vasc Surg; 2017 Aug 18; 66(2):507-514.e1. PubMed ID: 28433332
    [Abstract] [Full Text] [Related]

  • 15. Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source.
    Ntaios G, Lip GYH, Lambrou D, Michel P, Perlepe K, Eskandari A, Nannoni S, Sirimarco G, Strambo D, Vemmos K, Koroboki E, Manios E, Vemmou A, Rodríguez-Campello A, Cuadrado-Godia E, Roquer J, Arnao V, Caso V, Paciaroni M, Diez-Tejedor E, Fuentes B, Rodríguez Pardo J, Arauz A, Ameriso SF, Pertierra L, Gómez-Schneider M, Hawkes MA, Bandini F, Chavarria Cano B, Mohedano AMI, García Pastor A, Gil-Núñez A, Putaala J, Tatlisumak T, Barboza MA, Karagkiozi E, Makaritsis K, Papavasileiou V.
    Stroke; 2018 Dec 18; 49(12):2904-2909. PubMed ID: 30571398
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A 3-year follow-up study on cardiovascular disease and mortality in older people with intellectual disabilities.
    de Winter CF, van den Berge AP, Schoufour JD, Oppewal A, Evenhuis HM.
    Res Dev Disabil; 2016 Dec 18; 53-54():115-26. PubMed ID: 26874209
    [Abstract] [Full Text] [Related]

  • 20. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA.
    Am J Kidney Dis; 2011 Sep 18; 58(3):398-408. PubMed ID: 21783292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.